医疗保险人群中跛行胫动脉干预的使用模式
基于2017至2019年全美医疗保险按服务收费索赔数据,回顾性分析59,930例因跛行接受首次外周血管干预的患者,其中16,594例(27.7%)接受了胫动脉干预。多因素分析显示,男性、年龄增长、黑人种族、西班牙裔、糖尿病、无高血压史和从不吸烟与胫动脉干预相关;医生层面早期职业、西部地区、高手术量、门诊手术中心或办公室实验室执业及专科类别与胫动脉干预相关。血管外科医生行胫动脉干预的 odds 显著低于放射科医生(aOR 2.98)和心脏科医生(aOR 1.67)。
要点
- 27.7%的跛行患者首次外周血管干预接受了胫动脉干预。
- 医生层面胫动脉干预率中位数为20.0%(四分位距9.1%-37.5%)。
- 血管外科医生行胫动脉干预的 odds 显著低于放射科医生(aOR 2.98)和心脏科医生(aOR 1.67)。
核心结论
- 跛行胫动脉外周血管干预更常由非血管外科医生在高手术量和高报销环境中实施,因此亟需重新评估这些手术的适应证、教育和报销政策。
研究设计与样本
- 使用2017至2019年全美医疗保险按服务收费索赔数据,对因跛行接受首次外周血管干预的患者进行回顾性分析,排除既往12个月内任何外周血管干预、急性肢体缺血或慢性肢体威胁性缺血的患者。
- 纳入59,930例医疗保险患者和1542名医生,采用单变量比较和多变量分层逻辑回归评估与跛行胫动脉干预相关的患者和医生特征。
主要发现
- 在59,930例因跛行接受首次外周血管干预的医疗保险患者中,16,594例(27.7%)接受了胫动脉干预,其中孤立性胫动脉干预占38.5%,胫动脉干预联合股腘动脉干预占61.5%。
- 在纳入分析的1542名医生中,医生层面胫动脉干预率的中位数为20.0%(四分位距9.1%-37.5%)。
- 患者层面与胫动脉干预相关的特征包括男性(aOR 1.23)、年龄增长(aOR 1.30-1.96)、黑人种族(aOR 1.47)、西班牙裔(aOR 1.86)、糖尿病(aOR 1.36)、无高血压史(aOR 1.12)和从不吸烟状态(aOR 1.64;所有P < .05)。
- 医生层面与胫动脉干预相关的特征包括早期职业状态(aOR 2.97)、西部地区执业(aOR 1.75)、高手术量外周血管干预实践(aOR 1.87)、多数执业在门诊手术中心或办公室实验室环境(aOR 2.37)和医生专科。
- 血管外科医生行胫动脉干预的 odds 显著低于放射科医生(aOR 2.98)和心脏科医生(aOR 1.67;所有P < .05)。
关键数值与推荐
- 在59,930例因跛行接受首次外周血管干预的医疗保险患者中,16,594例(27.7%)接受了胫动脉干预。
- 医生层面胫动脉干预率中位数为20.0%(四分位距9.1%-37.5%)。
- 男性aOR 1.23、年龄增长aOR 1.30-1.96、黑人种族aOR 1.47、西班牙裔aOR 1.86、糖尿病aOR 1.36、无高血压史aOR 1.12、从不吸烟aOR 1.64(所有P < .05)。
- 早期职业状态aOR 2.97、西部地区执业aOR 1.75、高手术量实践aOR 1.87、门诊手术中心或办公室实验室环境aOR 2.37。
- 血管外科医生行胫动脉干预的 odds 显著低于放射科医生(aOR 2.98)和心脏科医生(aOR 1.67;所有P < .05)。
临床怎么用
- 作者认为,亟需重新评估跛行胫动脉外周血管干预的适应证、教育和报销政策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: At present, no data are available to support the use of tibial interventions in the treatment of claudication. We characterized the practice patterns surrounding tibial peripheral vascular interventions (PVIs) for patients with claudication in the United States. METHODS: Using 100% Medicare fee-for-service claims from 2017 to 2019, we conducted a retrospective analysis of all patients who underwent an index PVI for claudication. Patients with any previous PVI, acute limb ischemia, or chronic limb-threatening ischemia in the preceding 12 months were excluded. The primary outcome was the receipt or delivery of tibial revascularization during an index PVI for claudication, defined as tibial PVI with or without concomitant femoropopliteal PVI. Univariable comparisons and multivariable hierarchical logistic regression were used to assess the patient and physician characteristics associated with the use of tibial PVI for claudication. RESULTS: Of 59,930 Medicare patients who underwent an index PVI for claudication between 2017 and 2019, 16,594 (27.7%) underwent a tibial PVI (isolated tibial PVI, 38.5%; tibial PVI with concomitant femoropopliteal PVI, 61.5%). Of the 1542 physicians included in our analysis, the median physician-level tibial PVI rate was 20.0% (interquartile range, 9.1%-37.5%). Hierarchical logistic regression suggested that patient-level characteristics associated with tibial PVI for claudication included male sex (adjusted odds ratio [aOR], 1.23), increasing age (aOR, 1.30-1.96), Black race (aOR, 1.47), Hispanic ethnicity (aOR, 1.86), diabetes (aOR, 1.36), no history of hypertension (aOR, 1.12), and never-smoking status (aOR, 1.64; P < .05 for all). Physician-level characteristics associated with tibial PVI for claudication included early-career status (aOR, 2.97), practice location in the West (aOR, 1.75), high-volume PVI practice (aOR, 1.87), majority of practice in an ambulatory surgery center or office-based laboratory setting (aOR, 2.37), and physician specialty. The odds of vascular surgeons performing tibial PVI were significantly lower compared with radiologists (aOR, 2.98) and cardiologists (aOR, 1.67; P < .05 for all). The average Medicare reimbursement per patient was dramatically higher for physicians performing high rates of tibial PVI (quartile 4 vs quartile 1-3, $12,023.96 vs $692.31 per patient; P < .001). CONCLUSIONS: Tibial PVI for claudication was performed more often by nonvascular surgeons in high-volume practices and high-reimbursement settings. Thus, a critical need exists to reevaluate the indications, education, and reimbursement policies surrounding these procedures.
引用
- Bose S, Dun C, Sorber R, et al. Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population. J Vasc Surg. 2022. PMID: 36058433. doi:10.1016/j.jvs.2022.08.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。